Literature DB >> 26550422

One-stent versus two-stent techniques for distal unprotected left main coronary artery bifurcation lesions.

Jiangang Zhang1, Shuai Liu1, Tao Geng1, Zesheng Xu1.   

Abstract

OBJECTIVE: To assess the clinical outcomes of percutaneous coronary intervention (PCI) with single-stent versus double-stents implantation in distal unprotected left main coronary artery (ULMCA) bifurcation lesions and evaluate their merits and demerits in this clinical setting.
METHODS: 88 patients with distal ULMCA bifurcation lesions and treated with PCI with single or double stents implantation (50 in the one-stent group and 38 in the two-stent group) was included.
RESULTS: No significant difference in the number of left main and multivessel disease, stenosis rate of left main, inner diameter of left main vessel, and distal bifurcation angle was noted. The procedural success rate was 100%. Single-stent group had significantly lower ostial residual stenosis of left anterior descending and higher ostial residual stenosis of left circumflex as compared to double-stent group. During the hospitalization period, no major adverse cardiovascular events were observed in the two groups. During the follow-up period, restenosis was observed in 1 case in single-stent group and in 2 cases in double-stent group, respectively. Recurrence of angina and target lesion revascularization was observed in 6 and 1 case in single-stent group, and 4 and 2 cases in double-stent group, respectively. There was no acute myocardial infarction, in-stent thrombosis and cardiac death in both of the groups.
CONCLUSIONS: Both stenting strategies were feasible for distal ULMCA bifurcation lesions with a high operation success rate and safety. Single-stent technique had lower ostial residual stenosis of left anterior descending whereas double-stents technique had lower ostial residual stenosis of left circumflex.

Entities:  

Keywords:  Unprotected left main coronary artery; bifurcation lesions; percutaneous coronary intervention; stent

Year:  2015        PMID: 26550422      PMCID: PMC4613107     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  22 in total

1.  Unprotected left main stenting with a second-generation drug-eluting stent: one-year outcomes of the LEMAX Pilot study.

Authors:  Neus Salvatella; Marie-Claude Morice; Olivier Darremont; Muriel Tafflet; Philippe Garot; Jean Louis Leymarie; Bernard Chevalier; Thierry Lefèvre; Yves Louvard; Nicolas Boudou; Nicolas Dumonteil; Didier Carrié
Journal:  EuroIntervention       Date:  2011-10-30       Impact factor: 6.534

2.  Long-term outcomes after stenting of bifurcation lesions with the "crush" technique: predictors of an adverse outcome.

Authors:  Angela Hoye; Ioannis Iakovou; Lei Ge; Carlos A G van Mieghem; Andrew T L Ong; John Cosgrave; Giuseppe M Sangiorgi; Flavio Airoldi; Matteo Montorfano; Iassen Michev; Alaide Chieffo; Mauro Carlino; Nicola Corvaja; Jiro Aoki; Gaston A Rodriguez Granillo; Marco Valgimigli; Georgios Sianos; Willem J van der Giessen; Pim J de Feyter; Ron T van Domburg; Patrick W Serruys; Antonio Colombo
Journal:  J Am Coll Cardiol       Date:  2006-04-24       Impact factor: 24.094

3.  Comparison of simple and complex stenting techniques in the treatment of unprotected left main coronary artery bifurcation stenosis.

Authors:  Young-Hak Kim; Seong-Wook Park; Myeong-Ki Hong; Duk-Woo Park; Kyoung-Min Park; Bong-Ki Lee; Jong-Min Song; Ki-Hoon Han; Cheol Whan Lee; Duk-Hyun Kang; Jae-Kwan Song; Jae-Joong Kim; Seung-Jung Park
Journal:  Am J Cardiol       Date:  2006-04-07       Impact factor: 2.778

4.  Stents versus coronary-artery bypass grafting for left main coronary artery disease.

Authors:  Ki Bae Seung; Duk-Woo Park; Young-Hak Kim; Seung-Whan Lee; Cheol Whan Lee; Myeong-Ki Hong; Seong-Wook Park; Sung-Cheol Yun; Hyeon-Cheol Gwon; Myung-Ho Jeong; Yangsoo Jang; Hyo-Soo Kim; Pum Joon Kim; In-Whan Seong; Hun Sik Park; Taehoon Ahn; In-Ho Chae; Seung-Jea Tahk; Wook-Sung Chung; Seung-Jung Park
Journal:  N Engl J Med       Date:  2008-03-31       Impact factor: 91.245

Review 5.  2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Authors:  Frederick G Kushner; Mary Hand; Sidney C Smith; Spencer B King; Jeffrey L Anderson; Elliott M Antman; Steven R Bailey; Eric R Bates; James C Blankenship; Donald E Casey; Lee A Green; Judith S Hochman; Alice K Jacobs; Harlan M Krumholz; Douglass A Morrison; Joseph P Ornato; David L Pearle; Eric D Peterson; Michael A Sloan; Patrick L Whitlow; David O Williams
Journal:  J Am Coll Cardiol       Date:  2009-12-01       Impact factor: 24.094

6.  Disease of the left main coronary artery. Surgical treatment and long-term follow up in 267 patients.

Authors:  J B Farinha; M A Kaplan; C N Harris; E F Dunne; R A Carlish; J H Kay; S Brooks
Journal:  Am J Cardiol       Date:  1978-07       Impact factor: 2.778

7.  Sirolimus-eluting stent implantation for unprotected left main coronary artery stenosis: comparison with bare metal stent implantation.

Authors:  Seung-Jung Park; Young-Hak Kim; Bong-Ki Lee; Seung-Whan Lee; Cheol Whan Lee; Myeong-Ki Hong; Jae-Joong Kim; Gary S Mintz; Seong-Wook Park
Journal:  J Am Coll Cardiol       Date:  2005-02-01       Impact factor: 24.094

8.  Paclitaxel- versus sirolimus-eluting stents for unprotected left main coronary artery disease.

Authors:  Julinda Mehilli; Adnan Kastrati; Robert A Byrne; Olga Bruskina; Raisuke Iijima; Stefanie Schulz; Jürgen Pache; Melchior Seyfarth; Steffen Massberg; Karl-Ludwig Laugwitz; Josef Dirschinger; Albert Schömig
Journal:  J Am Coll Cardiol       Date:  2009-05-12       Impact factor: 24.094

9.  Ostial and midshaft lesions vs. bifurcation lesions in 1111 patients with unprotected left main coronary artery stenosis treated with drug-eluting stents: results of the survey from the Italian Society of Invasive Cardiology.

Authors:  Tullio Palmerini; Diego Sangiorgi; Antonio Marzocchi; Corrado Tamburino; Imad Sheiban; Massimo Margheri; Giuseppe Vecchi; Giuseppe Sangiorgi; Michele Ruffini; Antonio L Bartorelli; Carlo Briguori; Luigi Vignali; Francesco Di Pede; Angelo Ramondo; Luigi Inglese; Marco De Carlo; Leonardo Bolognese; Alberto Benassi; Cataldo Palmieri; Vincenzo Filippone; Fabio Barlocco; Giulia Lauria; Stefano De Servi
Journal:  Eur Heart J       Date:  2009-06-09       Impact factor: 29.983

10.  ACCF/SCAI/STS/AATS/AHA/ASNC 2009 Appropriateness Criteria for Coronary Revascularization: a report by the American College of Cardiology Foundation Appropriateness Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, and the American Society of Nuclear Cardiology Endorsed by the American Society of Echocardiography, the Heart Failure Society of America, and the Society of Cardiovascular Computed Tomography.

Authors:  Manesh R Patel; Gregory J Dehmer; John W Hirshfeld; Peter K Smith; John A Spertus
Journal:  J Am Coll Cardiol       Date:  2009-02-10       Impact factor: 24.094

View more
  3 in total

Review 1.  Percutaneous Coronary Intervention for Bifurcation: How Can We Outperform the Provisional Strategy?

Authors:  Andrew Kei-Yan Ng; Man-Hong Jim
Journal:  Clin Cardiol       Date:  2016-08-24       Impact factor: 2.882

Review 2.  One- and 3-year outcomes of percutaneous bifurcation left main revascularization with modern drug-eluting stents: a systematic review and meta-analysis.

Authors:  Gianluca Rigatelli; Marco Zuin; Pavel Nikolov; Nyha Mileva; Dobrin Vassilev
Journal:  Clin Res Cardiol       Date:  2020-05-30       Impact factor: 5.460

3.  Comparison of transradial coronary intervention for left main bifurcation disease using the new Braidin® slender 7 Fr sheath and a standard 6 Fr sheath.

Authors:  Yingkai Xu; Yingkai Li; Jiancai Yu; Deguang Wang; Qi Zhao; Yujing Cheng; Yujie Zhou
Journal:  J Int Med Res       Date:  2020-09       Impact factor: 1.671

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.